
Cellectar Biosciences Inc
NASDAQ:CLRB

Intrinsic Value
The intrinsic value of one
CLRB
stock under the Base Case scenario is
3.46
USD.
Compared to the current market price of 5.28 USD,
Cellectar Biosciences Inc
is
Overvalued by 34%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Cellectar Biosciences Inc
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
Cellectar Biosciences Inc
Balance Sheet Decomposition
Cellectar Biosciences Inc
Current Assets | 12.6m |
Cash & Short-Term Investments | 11m |
Other Current Assets | 1.6m |
Non-Current Assets | 1.1m |
PP&E | 1m |
Other Non-Current Assets | 29.8k |
Free Cash Flow Analysis
Cellectar Biosciences Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Cellectar Biosciences Inc
Revenue
|
0
USD
|
Operating Expenses
|
-38.5m
USD
|
Operating Income
|
-38.5m
USD
|
Other Expenses
|
9.4m
USD
|
Net Income
|
-29.1m
USD
|
CLRB Profitability Score
Profitability Due Diligence
Cellectar Biosciences Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Score
Cellectar Biosciences Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
CLRB Solvency Score
Solvency Due Diligence
Cellectar Biosciences Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Score
Cellectar Biosciences Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CLRB Price Targets Summary
Cellectar Biosciences Inc
Dividends
Current shareholder yield for CLRB is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CLRB
stock under the Base Case scenario is
3.46
USD.
Compared to the current market price of 5.28 USD,
Cellectar Biosciences Inc
is
Overvalued by 34%.